PAFAH1B3 and cutaneous melanoma: PAFAH1B3 expression was higher in ACC, BLCA, BRCA, cervical squamous cell carcinoma (CESC), COAD, CHOL, diffuse large B-cell lymphoma (DLBCL), ESCA, glioblastoma (GBM), HNSC, KIRP, low-grade glioma (LGG), LIHC, LUAD, LUSC, ovarian cancer (OV), pancreatic adenocarcinoma (PAAD), PRAD, READ, skin cutaneous melanoma (SKCM), STAD, tenosynovial giant cell tumor (TGCT), THCA, thymus cancer (THYM), UCEC, and uterine carcinosarcoma (UCS) (Figure 1B).